[1] |
Prieto ML, Cuéllar-Barboza AB, Bobo WV, et al. Risk of myocardial infarction and stroke in bipolar disorder:a systematic review and exploratory Meta-analysis[J]. Acta Psychiatr Scand, 2014, 130(5): 342-353. DOI:10.1111/acps.12293 |
|
[2] |
Correll CU, Solmi M, Veronese N, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness:a large-scale Meta-analysis of 3211768 patients and 113383368 controls[J]. World Psychiatry, 2017, 16(2): 163-180. DOI:10.1002/wps.20420 |
|
[3] |
Regenold WT, Thapar RK, Marano C, et al. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar Ⅰ affective and schizoaffective disorders independent of psychotropic drug use[J]. J Affect Disord, 2002, 70(1): 19-26. DOI:10.1016/S0165-0327(01)00456-6 |
|
[4] |
Fagiolini A, Frank E, Scott JA, et al. Metabolic syndrome in bipolar disorder:findings from the bipolar disorder center for Pennsylvanians[J]. Bipolar Disord, 2005, 7(5): 424-430. DOI:10.1111/j.1399-5618.2005.00234.x |
|
[5] |
Vancampfort D, Correll CU, Galling B, et al. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder:a systematic review and large scale Meta-analysis[J]. World Psychiatry, 2016, 15(2): 166-174. DOI:10.1002/wps.20309 |
|
[6] |
Wandell P, Ljunggren G, Wahlström L, et al. Diabetes and psychiatric illness in the total population of Stockholm[J]. J Psychosomat Res, 2014, 77(3): 169-173. DOI:10.1016/j.jpsychores.2014.06.012 |
|
[7] |
Leopold K, Reif A, Haack S, et al. Type 2 diabetes and pre-diabetic abnormalities in patients with bipolar disorders[J]. J Affect Disord, 2016, 189: 240-245. DOI:10.1016/j.jad.2015.09.041 |
|
[8] |
郝凤仪, 张道龙. 双相及相关障碍的核心特征与治疗[J]. 四川精神卫生, 2017, 30(3): 294-296. Hao FY, Zhang DL. Core symptoms and treatments of bipolar and related disorders[J]. Sichuan Mental Health, 2017, 30(3): 294-296. DOI:10.11886/j.issn.1007-3256.2017.03.022 |
|
[9] |
American Psychiatric Association. Diagnostic and statistical manual of mental disorders[M]. 5th ed. Arlington: American Psychiatric Publishing, 2013.
|
|
[10] |
Fox CS, Golden SH, Anderson C, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence:a scientific statement from the American heart association and the American diabetes association[J]. Diabetes Care, 2015, 38(9): 1777-1803. DOI:10.2337/dci15-0012 |
|
[11] |
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1789-1858. DOI:10.1016/S0140-6736(18)32279-7 |
|
[12] |
吴霞民, 马宁, 王勋, 等. 2017年全国严重精神障碍患者管理治疗现状分析[J]. 中华精神科杂志, 2019, 52(1): 82-88. Wu XM, Ma N, Wang X, et al. Management and services for psychosis in People's Republic of China in 2017[J]. Chin J Psychiatry, 2019, 52(1): 82-88. DOI:10.3760/cma.j.issn.1006-7884.2019.01.008 |
|
[13] |
Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative[J]. Arch Gen Psychiatry, 2011, 68(3): 241-251. DOI:10.1001/archgenpsychiatry.2011.12 |
|
[14] |
Huang YQ, Wang Y, Wang H, et al. Prevalence of mental disorders in China:a cross-sectional epidemiological study[J]. Lancet Psychiatry, 2019, 6(3): 211-224. DOI:10.1016/S2215-0366(18)30511-X |
|
[15] |
Chien IC, Chang KC, Lin CH, et al. Prevalence of diabetes in patients with bipolar disorder in Taiwan:a population-based national health insurance study[J]. Gen Hosp Psychiatry, 2010, 32(6): 577-582. DOI:10.1016/j.genhosppsych.2010.09.005 |
|
[16] |
Vancampfort D, Mitchell AJ, de Hert M, et al. Prevalence and predictors of type 2 diabetes mellitus in people with bipolar disorder:a systematic review and Meta-analysis[J]. J Clin Psychiatry, 2015, 76(11): 1490-1499. DOI:10.4088/JCP.14r09635 |
|
[17] |
Calkin CV, Ruzickova M, Uher R, et al. Insulin resistance and outcome in bipolar disorder[J]. Br J Psychiatry, 2015, 206(1): 52-57. DOI:10.1192/bjp.bp.114.152850 |
|
[18] |
Bai YM, Su TP, Chen MH, et al. Risk of developing diabetes mellitus and hyperlipidemia among patients with bipolar disorder, major depressive disorder, and schizophrenia:a 10-year nationwide population-based prospective cohort study[J]. J Affect Disord, 2013, 150(1): 57-62. DOI:10.1016/j.jad.2013.02.019 |
|
[19] |
Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas:Global estimates of diabetes prevalence for 2017 and projections for 2045[J]. Diabetes Res Clin Pract, 2018, 138: 271-281. DOI:10.1016/j.diabres.2018.02.023 |
|
[20] |
de Hert M, Cohen D, Bobes J, et al. Physical illness in patients with severe mental disorders. Ⅱ. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level[J]. World Psychiatry, 2011, 10(2): 138-151. DOI:10.1002/j.2051-5545.2011.tb00036.x |
|
[21] |
Fries GR, Vasconcelos-Moreno MP, Gubert C, et al. Hypothalamic-pituitary-adrenal axis dysfunction and illness progression in bipolar disorder[J]. Int J Neuropsychopharmacol, 2014, 18(1): pyu043. DOI:10.1093/ijnp/pyu043 |
|
[22] | |
|
[23] |
Scaini G, Rezin GT, Carvalho AF, et al. Mitochondrial dysfunction in bipolar disorder:Evidence, pathophysiology and translational implications[J]. Neurosci Biobehav Rev, 2016, 68: 694-713. DOI:10.1016/j.neubiorev.2016.06.040 |
|
[24] |
Joseph JJ, Golden SH. Cortisol dysregulation:the bidirectional link between stress, depression, and type 2 diabetes mellitus[J]. Ann N Y Acad Sci, 2017, 1391(1): 20-34. DOI:10.1111/nyas.13217 |
|
[25] | |
|
[26] | |
|
[27] |
Szendroedi J, Schmid AI, Chmelik M, et al. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes[J]. PLoS Med, 2007, 4(5): e154. DOI:10.1371/journal.pmed.0040154 |
|
[28] |
Chen MH, Li CT, Lin WC, et al. A predisposition for allergies predicts subsequent hypertension, dyslipidemia, and diabetes mellitus among patients with schizophrenia or bipolar disorder:a nationwide longitudinal study[J]. Schizophr Res, 2014, 159(1): 171-175. DOI:10.1016/j.schres.2014.07.029 |
|
[29] |
Wang X, Bao W, Liu J, et al. Inflammatory markers and risk of type 2 diabetes:a systematic review and Meta-analysis[J]. Diabetes Care, 2013, 36(1): 166-175. DOI:10.2337/dc12-0702 |
|
[30] |
Horrobin DF, Bennett CN. Depression and bipolar disorder:relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis Possible candidate genes[J]. Prostaglandins Leukot Essent Fatty Acids, 1999, 60(4): 217-234. DOI:10.1054/plef.1999.0037 |
|
[31] |
Salvadore G, Viale CI, Luckenbaugh DA, et al. Increased uric acid levels in drug-naive subjects with bipolar disorder during a first manic episode[J]. Prog Neuro-Psychopharmacol Biol Psychiatry, 2010, 34(6): 819-821. DOI:10.1016/j.pnpbp.2010.02.027 |
|
[32] |
Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3β in cellular signaling[J]. Prog Neurobiol, 2001, 65(4): 391-426. DOI:10.1016/S0301-0082(01)00011-9 |
|
[33] |
Lovestone S, Killick R, Di Forti M, et al. Schizophrenia as a GSK-3 dysregulation disorder[J]. Trends Neurosci, 2007, 30(4): 142-149. DOI:10.1016/j.tins.2007.02.002 |
|
[34] |
Iwen KA, Schröder E, Brabant G. Thyroid hormones and the metabolic syndrome[J]. Eur Thyroid J, 2013, 2(2): 83-92. DOI:10.1159/000351249 |
|
[35] |
Torkamani A, Topol EJ, Schork NJ. Pathway analysis of seven common diseases assessed by genome-wide association[J]. Genomics, 2008, 92(5): 265-272. DOI:10.1016/j.ygeno.2008.07.011 |
|
[36] | |
|
[37] |
Elmslie JL, Mann JI, Silverstone JT, et al. Determinants of overweight and obesity in patients with bipolar disorder[J]. J Clin Psychiatry, 2001, 62(6): 486-491. DOI:10.4088/JCP.v62n0614 |
|
[38] |
Sylvia LG, Dupuy JM, Ostacher MJ, et al. Sleep disturbance in euthymic bipolar patients[J]. J Psychopharmacol, 2012, 26(8): 1108-1112. DOI:10.1177/0269881111421973 |
|
[39] |
Ruetsch O, Viala A, Bardou H, et al. Psychotropic drugs induced weight gain:a review of the literature concerning epidemiological data, mechanisms and management[J]. L'Encéphale, 2005, 31(4): 507-516. DOI:10.1016/S0013-7006(05)82412-1 |
|
[40] |
Calkin CV, Gardner DM, Ransom T, et al. The relationship between bipolar disorder and type 2 diabetes:more than just co-morbid disorders[J]. Ann Med, 2013, 45(2): 171-181. DOI:10.3109/07853890.2012.687835 |
|
[41] |
Sharma AN, Bauer IE, Sanches M, et al. Common biological mechanisms between bipolar disorder and type 2 diabetes:Focus on inflammation[J]. Prog Neuro-Psychopharmacol Biol Psychiatry, 2014, 54: 289-298. DOI:10.1016/j.pnpbp.2014.06.005 |
|
[42] |
Charles EF, Lambert CG, Kerner B. Bipolar disorder and diabetes mellitus:evidence for disease-modifying effects and treatment implications[J]. Int J Bipolar Disord, 2016, 4: 13. DOI:10.1186/s40345-016-0054-4 |
|
[43] |
Lin EHB, Katon W, von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care[J]. Diabetes Care, 2004, 27(9): 2154-2160. DOI:10.2337/diacare.27.9.2154 |
|
[44] |
Ruzickova M, Slaney C, Garnham J, et al. Clinical features of bipolar disorder with and without comorbid diabetes mellitus[J]. Can J Psychiatry, 2003, 48(7): 458-461. DOI:10.1177/070674370304800705 |
|
[45] |
Frayne SM, Halanych JH, Miller DR, et al. Disparities in diabetes care:impact of mental illness[J]. Arch Intern Med, 2005, 165(22): 2631-2638. DOI:10.1001/archinte.165.22.2631 |
|
[46] | |
|
[47] |
Ayerbe L, Forgnone I, Addo J, et al. Hypertension risk and clinical care in patients with bipolar disorder or schizophrenia:a systematic review and Meta-analysis[J]. J Affect Disord, 2018, 225: 665-670. DOI:10.1016/j.jad.2017.09.002 |
|
[48] |
Goldstein BI, Carnethon MR, Matthews KA, et al. Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease:a scientific statement from the American heart association[J]. Circulation, 2015, 132(10): 965-986. DOI:10.1161/CIR.0000000000000229 |
|
[49] |
Mangurian C, Newcomer JW, Modlin C, et al. Diabetes and cardiovascular care among people with severe mental illness:a literature review[J]. J Gen Intern Med, 2016, 31(9): 1083-1091. DOI:10.1007/s11606-016-3712-4 |
|
[50] |
Grøn AO, Dalsgaard EM, Ribe AR, et al. Improving diabetes care among patients with severe mental illness:A systematic review of the effect of interventions[J]. Prim Care Diabetes, 2018, 12(4): 289-304. DOI:10.1016/j.pcd.2018.03.008 |
|
[51] |
Datusalia AK, Sharma SS. Amelioration of diabetes-induced cognitive deficits by GSK-3β inhibition is attributed to modulation of neurotransmitters and neuroinflammation[J]. Mol Neurobiol, 2014, 50(2): 390-405. DOI:10.1007/s12035-014-8632-x |
|
[52] |
King MR, Anderson NJ, Guernsey LS, et al. Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice[J]. J Neurosci Res, 2013, 91(4): 506-514. DOI:10.1002/jnr.23192 |
|
[53] |
Ladefoged M, Buschard K, Hansen AM. Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes[J]. APMIS, 2013, 121(6): 531-538. DOI:10.1111/apm.12018 |
|
[54] |
Lucas K, Maes M. Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation:possible treatments targeting the TLR4 pathway[J]. Mol Neurobiol, 2013, 48(1): 190-204. DOI:10.1007/s12035-013-8425-7 |
|
[55] |
Zeinoddini A, Sorayani M, Hassanzadeh E, et al. Pioglitazone adjunctive therapy for depressive episode of bipolar disorder:a randomized, double-blind, placebo-controlled trial[J]. Depress Anxiety, 2015, 32(3): 167-173. DOI:10.1002/da.22340 |
|